Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7101439

NC(C(=O)NCCCc1ccccc1)C(=O)NCCCc1ccccc1.O=C(O)C(F)(F)F

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.60
CYP2C9 P11712 1/20 0.60
CYP2C19 P33261 1/20 0.60
KMT2A Q03164 1/20 0.60
CNR1 P21554 2/20 0.58
MMP8 P22894 3/20 0.57
MLYCD O95822 2/20 0.56
TACR1 P25103 1/20 0.54
KDM4A O75164 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
POLB P06746 1/20 0.52
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
GAA P10253 1/20 0.51
HPGD P15428 1/20 0.51
CNR2 P34972 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7103734 0.91 MLYCD (0.54) CYP2D6CYP2C9CYP2C19KMT2AMLYCD
Trifluoroacetic Acid SCHEMBL7955825 0.87 CYP2D6 (0.55) CYP2D6CYP2C9CYP2C19KMT2ACNR1
Trifluoroacetic Acid SCHEMBL7101192 0.82 MMP8 (0.53) CYP2D6CYP2C9CYP2C19KMT2AMMP8
Trifluoroacetic Acid SCHEMBL27530667 0.81 CYP2D6 (0.48) CYP2D6CYP2C9CYP2C19KMT2ACNR1
Trifluoroacetic Acid SCHEMBL7067825 0.80 MMP8 (0.54) CYP2D6CYP2C9CYP2C19KMT2ACNR1
SCHEMBL10423181 0.79 KMT2A (0.77) CYP2D6CYP2C9CYP2C19KMT2ACNR1
SCHEMBL10611159 0.79 KMT2A (0.77) CYP2D6CYP2C9CYP2C19KMT2ACNR1
SCHEMBL10627851 0.79 KMT2A (0.77) CYP2D6CYP2C9CYP2C19KMT2ACNR1
SCHEMBL6155598 0.79 POLB (0.71) CYP2D6CYP2C9CYP2C19KMT2ACNR1
SCHEMBL13690869 0.78 KMT2A (0.66) CYP2D6CYP2C9CYP2C19KMT2ACNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140818-B1 AMIDOMALONAMIDES AND THEIR USE AS INHIBITORS OF MATRIX METALLOPROTEINASE AVENTIS PHARMA INC (US) 2003-09-10 EP disclosed
US-6329550-B1 FOR THERAPY OF EMPHYSEMA, OSTEOPOROSIS, RHEUMATOID ARTHRITIS AND NEOPLASTIC DISEASES AVENTIS PHARMACEUTICALS INC. 2001-12-11 US disclosed
EP-1140818-A1 AMIDOMALONAMIDES AND THEIR USE AS INHIBITORS OF MATRIX METALLOPROTEINASE Aventis Pharmaceuticals Inc. (US) 2001-10-10 EP disclosed
WO-2000040552-A1 AMIDOMALONAMIDES AND THEIR USE AS INHIBITORS OF MATRIX METALLOPROTEINASE AVENTIS PHARMACEUTICALS INC. (US) 2000-07-13 WO disclosed